Clonazepam
Company: Watson PharmaceuticalsApproval Status: Approved January 1998
Treatment for: anticonvulsant
Areas: Neurology & Nervous System
General Information
Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.
Clonazepam Drug Information
The Clonazepam drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
